Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension

Clinical Science

Volumn 103, Issue 5, 2002, Pages 493-499

  Deary, Alison J ^a   Schumann, Anne L ^a   Murfet, Helen ^a   Haydock, Stephen ^a   Foo, Roger S ^a   Brown, Morris J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Augmentation index; Brain natriuretic peptide; Crossover trial; Pulse wave; blockade

Indexed keywords

AMLODIPINE; ATRIAL NATRIURETIC FACTOR; BENDROFLUMETHIAZIDE; BRAIN NATRIURETIC PEPTIDE; DOXAZOSIN; LISINOPRIL; PLACEBO;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED DISEASE; ESSENTIAL HYPERTENSION; FEMALE; HEART MUSCLE CELL; HORMONE RELEASE; HUMAN; MALE; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TONOMETRY;

EID: 0036847184     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs1030493     Document Type: Article

References (39)

1. Blood Pressure Lowering Treatment Triallists Collaboration (2000) Effects of angiotensin converting enzyme inhibitors, calcium antagonists and other blood pressure lowering drugs on mortality and major cardiovascular morbidity. Lancet 356, 1955-1964
2. Staessen, J. A., Wang, J. G. and Thijs, L. (2001) Cardiovascular protection and blood pressure reduction: A meta-analysis. Lancet 358, 1305-1315
3. Pahor, M., Psaty, B. M., Alderman, M. H. et al. (2000) Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: A meta-analysis of randomised controlled trials. Lancet 356, 1949-1954
4. Brown, M. J., Palmer, C. R., Castaigne, A. et al. (2000) Morbidity and mortality in patients randomised to double-blind treatment with once-daily calcium channel blockade or diuretic in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 356, 366-342
5. ALLHAT Collaborative Research Group (2000) Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA, J. Am. Med. Assoc. 283, 1967-1975
6. Dahlof, B., Devereux, R. B., Kjeldsen, S. E. et al. (2002) The losartan intervention for endpoint reduction in hypertension study. Lancet 359, 995-1003
7. Verdecchia, P., Schillaci, G., Reboldi, G., Franklin, S. S. and Porcellati, C. (2001) Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation 103, 2579-2584
8. Millar, J. A. and Lever, A. F. (2000) Implications of pulse pressure as a predictor of cardiac risk in patients with hypertension. Hypertension 36, 907-911
9. Deary, A., Schumann, A., Murfet, H., Haydock, S., Foo, R. and Brown, M. J. (2002) Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs. J. Hypertens. 20, 771-777
10. Chen, C. H., Nevo, E., Fetics, B. et al. (1997) Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 95, 1827-1836
11. Wilkinson, I. B., Fuchs, S. A., Jansen, I. M. et al. (1998) Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J. Hypertens. 16, 2079-2084
12. Pauca, A. L., O'Rourke, M. F. and Kon, N. D. (2001) Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 38, 932-937
13. O'Rourke, M. F. and Mancia, G. (1999) Arterial stiffness. J. Hypertens. 17, 1-4
14. Hayward, C. S. and Kelly, R. P. (1997) Gender-related differences in the central arterial pressure waveform. J. Am. Coll. Cardiol. 30, 1863-1871
15. Marchais, S. J., Guerin, A. P., Pannier, B. M., Levy, B. I., Safar, M. E. and London, G. M. (1993) Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size. Hypertension 22, 876-883
16. Yasmin and Brown, M. J. (1999) Similarities and differences between augmentation index and pulse wave velocity in the assessment of arterial stiffness. Q. J. Med. 92, 595-600
17. Wilkinson, I. B., MacCallum, H., Flint, L., Cockcroft, J. R., Newby, D. E. and Webb, D. J. (2000) The influence of heart rate on augmentation index and central arterial pressure in humans. J. Physiol. (Cambridge, U.K.). 525, 263-270
18. Albaladejo, P. (2001) Heart tare, arterial stiffness and wave reflections in paced patients. Hypertension 38, 949-952
19. Chen, C. H., Ting, C. T., Lin, S. J. et al. (1995) Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension 25, 1034-1041
20. Kelly, R., Daley, J., Avolio, A. and O'Rourke, M. (1989) Arterial dilation and reduced wave reflection. Benefit of dilevalol in hypertension. Hypertension 14, 14-21
21. Luchner, A., Burnett, J. C., Jougasaki, M. et al. (2000) Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J. Hypertens. 18, 1121-1128
22. Luchner, A., Burnett, Jr, J. C., Jougasaki, M., Hense, H. W., Riegger, G. A. and Schunkert, H. (1998) Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: Evidence from a population-based study. J. Am. Coll. Cardiol. 32, 1839-1844
23. London, G. M., Guerin, A. P., Pannier, B., Marchais, S. J. and Stimpel, M. (1995) Influence of sex on arterial hemodynamics and blood pressure. Role of body height. Hypertension 26, 514-519
24. Asmar, R., Hugues, C., Pannier, B., Daou, J. and Safar, M. E. (1987) Duration of action of bisoprolol after cessation of a 4 week treatment and its influence on pulse wave velocity and aortic diameter: A pilot study in hypertensive patients. Eur. Heart J. 8 (Suppl. M), 115-120
25. Asmar, R. G., Kerihuel, J. C., Girerd, X. J. and Safar, M. E. (1991) Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension. Am. J. Cardiol. 68, 61-64
26. Liang, F., Wu, J., Garami, M. and Gardner, D. G. (1997) Mechanical strain increases expression of the brain natriuretic peptide gene in rat cardiac myocytes. J. Biol. Chem. 272, 28050-28056
27. Cheung, B. M. and Brown, M. J. (1993) New natriuretic peptides and blood pressure. Lancet 342, 984
28. Westerhof, N. and O'Rourke, M. F. (1995) Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J. Hypertens. 13, 943-952
29. Nakaoka, H., Kitahara, Y., Amano, M. et al. (1987) Effect of beta-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension. Hypertension 10, 221-225
30. Struthers, A. D. (2000) The diagnosis of heart failure. Heart 84, 334-338
31. Yamamoto, K., Burnett, J. C., Jougasaki, M. et al. (1996) Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28, 988-994
32. He, Q., Wu, G. and Lapointe, M. C. (2000) Isoproterenol and cAMP regulation of the human brain natriuretic peptide gene involves Src and Rac. Am. J. Physiol. Endocrinol. Metab. 278, E1115-E1123
33. Liang, F. and Gardner, D. G. (1999) Mechanical strain activates BNP gene transcription through a p38/NF-κB-dependent mechanism. J. Clin. Invest. 104, 1603-1612
34. Ohta, Y., Watanabe, K., Nakazawa, M. et al. (2000) Carvedilol enhances atrial and brain natriuretic peptide mRNA expression and release in rat heart. J. Cardiovasc. Pharmacol. 36 (Suppl. 2), S19-S23
35. Cheung, B. M., Dickerson, J. E., Ashby, M. J., Brown, M. J. and Brown, J. (1994) Effects of physiological increments in human α-atrial natriuretic peptide and human brain natriuretic peptide in normal male subjects. Clin. Sci. 86, 723-730
36. Holmes, S. J., Espiner, E. A., Richards, A. M., Yandle, T. G. and Frampton, C. (1993) Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J. Clin. Endocrinol. Metab. 76, 91-96
37. La Villa, G., Fronzaroli, C., Lazzeri, C. et al. (1994) Cardiovascular and renal effects of low dose brain natriuretic peptide infusion in man. J. Clin. Endocrinol. Metab. 78, 1166-1171
38. Marcus, L. S., Hart, D., Packer, M. et al. (1996) Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial. Circulation 94, 3184-3189
39. Lee, E. Y. and Humphreys, M. H. (1996) Phosphodiesterase activity as a mediator of renal resistance to ANP in pathological salt retention. Am. J. Physiol. 271, F3-F6